Literature DB >> 2931414

Uptake of ciprofloxacin by human neutrophils.

C S Easmon, J P Crane.   

Abstract

Ciprofloxacin was concentrated within human neutrophils to between four and seven times the extracellular concentration. Uptake was rapid and dependent on temperature, but not pH. The elution of ciprofloxacin from cells was equally rapid when the extracellular concentration was reduced. Intracellular ciprofloxacin was biologically active. It produced a significant reduction in viable counts of intracellular Staphylococcus, aureus in the presence of extracellular concentrations as low as 0.5 mg/l. The prior ingestion of Staph. aureus by neutrophils appeared to have no effect on ciprofloxacin uptake.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2931414     DOI: 10.1093/jac/16.1.67

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  48 in total

1.  Gingival fluid ciprofloxacin levels at healthy and inflamed human periodontal sites.

Authors:  T B Conway; F M Beck; J D Walters
Journal:  J Periodontol       Date:  2000-09       Impact factor: 6.993

2.  Effect of ciprofloxacin on killing of Actinobacillus actinomycetemcomitans by polymorphonuclear leukocytes.

Authors:  David A Cacchillo; John D Walters
Journal:  Antimicrob Agents Chemother       Date:  2002-06       Impact factor: 5.191

3.  Accumulation of ciprofloxacin and minocycline by cultured human gingival fibroblasts.

Authors:  Q Yang; R J Nakkula; J D Walters
Journal:  J Dent Res       Date:  2002-12       Impact factor: 6.116

4.  In vitro demonstration of transport and delivery of antibiotics by polymorphonuclear leukocytes.

Authors:  M O Frank; G W Sullivan; H T Carper; G L Mandell
Journal:  Antimicrob Agents Chemother       Date:  1992-12       Impact factor: 5.191

Review 5.  Pulmonary disposition of antimicrobial agents: in vivo observations and clinical relevance.

Authors:  D R Baldwin; D Honeybourne; R Wise
Journal:  Antimicrob Agents Chemother       Date:  1992-06       Impact factor: 5.191

6.  Lack of effective bactericidal activity of new quinolones against Brucella spp.

Authors:  J A García-Rodriguez; J E García Sánchez; I Trujillano
Journal:  Antimicrob Agents Chemother       Date:  1991-04       Impact factor: 5.191

7.  In vitro and in vivo ciprofloxacin pharmacokinetics in human neutrophils.

Authors:  R Garraffo; D Jambou; R M Chichmanian; S Ravoire; P Lapalus
Journal:  Antimicrob Agents Chemother       Date:  1991-11       Impact factor: 5.191

8.  Mechanisms that may account for differential antibiotic susceptibilities among Coxiella burnetii isolates.

Authors:  M R Yeaman; O G Baca
Journal:  Antimicrob Agents Chemother       Date:  1991-05       Impact factor: 5.191

9.  Impact of the dosage schedule on the efficacy of ceftazidime, gentamicin and ciprofloxacin in Klebsiella pneumoniae pneumonia and septicemia in leukopenic rats.

Authors:  R Roosendaal; I A Bakker-Woudenberg; M van den Berghe-van Raffe; J C Vink-van den Berg; B M Michel
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1989-10       Impact factor: 3.267

Review 10.  Quinolones in Salmonella typhi infection.

Authors:  H L DuPont
Journal:  Drugs       Date:  1993       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.